{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:48:45Z","timestamp":1794322125388,"version":"4.9.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570175"],"award-info":[{"award-number":["81570175"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10875-020-00801-x","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T23:05:22Z","timestamp":1591225522000},"page":"718-728","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Prognostic Value of Blood-Based Inflammatory Biomarkers in Secondary Hemophagocytic Lymphohistiocytosis"],"prefix":"10.1007","volume":"40","author":[{"given":"Jiayu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangli","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jujuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"issue":"9","key":"801_CR1","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/ped.13064","volume":"58","author":"A Morimoto","year":"2016","unstructured":"Morimoto A, Nakazawa Y, Ishii E. Hemophagocytic lymphohistiocytosis: pathogenesis, diagnosis, and management. Pediatr Int. 2016;58(9):817\u201325. https:\/\/doi.org\/10.1111\/ped.13064.","journal-title":"Pediatr Int"},{"issue":"1","key":"801_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1532\/IJH97.07012","volume":"86","author":"E Ishii","year":"2007","unstructured":"Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86(1):58\u201365. https:\/\/doi.org\/10.1532\/IJH97.07012.","journal-title":"Int J Hematol"},{"issue":"6","key":"801_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.blre.2016.05.001","volume":"30","author":"A Hayden","year":"2016","unstructured":"Hayden A, Park S, Giustini D, Lee AY, Chen LY. Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review. Blood Rev. 2016;30(6):411\u201320. https:\/\/doi.org\/10.1016\/j.blre.2016.05.001.","journal-title":"Blood Rev"},{"issue":"2","key":"801_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331. https:\/\/doi.org\/10.1002\/pbc.21039.","journal-title":"Pediatr Blood Cancer"},{"issue":"17","key":"801_CR5","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1002\/cncr.30826","volume":"123","author":"N Daver","year":"2017","unstructured":"Daver N, McClain K, Allen CE, Parikh SA, Otrock Z, Rojas-Hernandez C, et al. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer. 2017;123(17):3229\u201340. https:\/\/doi.org\/10.1002\/cncr.30826.","journal-title":"Cancer."},{"issue":"4","key":"801_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.mayocp.2013.12.012","volume":"89","author":"SA Parikh","year":"2014","unstructured":"Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 2014;89(4):484\u201392. https:\/\/doi.org\/10.1016\/j.mayocp.2013.12.012.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"801_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00277-013-1925-8","volume":"93","author":"T Tsuji","year":"2014","unstructured":"Tsuji T, Hirano T, Yamasaki H, Tsuji M, Tsuda H. A high sIL-2R\/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann Hematol. 2014;93(5):821\u20136. https:\/\/doi.org\/10.1007\/s00277-013-1925-8.","journal-title":"Ann Hematol"},{"key":"801_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13023-015-0224-y","volume":"10","author":"F Li","year":"2015","unstructured":"Li F, Yang Y, Jin F, Dehoedt C, Rao J, Zhou Y, et al. Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China. Orphanet J Rare Dis. 2015;10:20. https:\/\/doi.org\/10.1186\/s13023-015-0224-y.","journal-title":"Orphanet J Rare Dis"},{"key":"801_CR9","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2147\/CMAR.S183784","volume":"11","author":"YZ Liu","year":"2019","unstructured":"Liu YZ, Bi LQ, Chang GL, Guo Y, Sun S. Clinical characteristics of extranodal NK\/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis. Cancer Manag Res. 2019;11:997\u20131002. https:\/\/doi.org\/10.2147\/CMAR.S183784.","journal-title":"Cancer Manag Res"},{"issue":"7","key":"801_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/1756-185X.12582","volume":"18","author":"AU Uslu","year":"2015","unstructured":"Uslu AU, Kucuk A, Sahin A, Ugan Y, Yilmaz R, Gungor T, et al. Two new inflammatory markers associated with disease activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Int J Rheum Dis. 2015;18(7):731\u20135. https:\/\/doi.org\/10.1111\/1756-185X.12582.","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"801_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jbspin.2007.06.016","volume":"75","author":"B Kisacik","year":"2008","unstructured":"Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine. 2008;75(3):291\u20134. https:\/\/doi.org\/10.1016\/j.jbspin.2007.06.016.","journal-title":"Joint Bone Spine"},{"issue":"3","key":"801_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/SLA.0000000000001743","volume":"265","author":"JC Chan","year":"2017","unstructured":"Chan JC, Chan DL, Diakos CI, Engel A, Pavlakis N, Gill A, et al. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg. 2017;265(3):539\u201346. https:\/\/doi.org\/10.1097\/SLA.0000000000001743.","journal-title":"Ann Surg"},{"issue":"4","key":"801_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3325\/cmj.2015.56.334","volume":"56","author":"V Perisa","year":"2015","unstructured":"Perisa V, Zibar L, Sincic-Petricevic J, Knezovic A, Perisa I, Barbic J. Red blood cell distribution width as a simple negative prognostic factor in patients with diffuse large B-cell lymphoma: a retrospective study. Croat Med J. 2015;56(4):334\u201343. https:\/\/doi.org\/10.3325\/cmj.2015.56.334.","journal-title":"Croat Med J"},{"issue":"1","key":"801_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4103\/jcrt.JCRT_624_17","volume":"15","author":"B Bilgin","year":"2019","unstructured":"Bilgin B, Sendur MAN, Hizal M, Dede DS, Akinci MB, Kandil SU, et al. Prognostic effect of red cell distribution width-to-platelet ratio in colorectal cancer according to tumor stage and localization. J Cancer Res Ther. 2019;15(1):54\u201360. https:\/\/doi.org\/10.4103\/jcrt.JCRT_624_17.","journal-title":"J Cancer Res Ther"},{"key":"801_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1756-8722-5-40","volume":"5","author":"LJ Zhang","year":"2012","unstructured":"Zhang LJ, Xu J, Liu P, Ding CY, Li JY, Qiu HX, et al. The significance of 18F-FDG PET\/CT in secondary hemophagocytic lymphohistiocytosis. J Hematol Oncol. 2012;5:40. https:\/\/doi.org\/10.1186\/1756-8722-5-40.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"801_CR16","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00432-015-2094-z","volume":"142","author":"J Wang","year":"2016","unstructured":"Wang J, Wang D, Zhang Q, Duan L, Tian T, Zhang X, et al. The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable. J Cancer Res Clin Oncol. 2016;142(4):859\u201371. https:\/\/doi.org\/10.1007\/s00432-015-2094-z.","journal-title":"J Cancer Res Clin Oncol"},{"key":"801_CR17","doi-asserted-by":"publisher","first-page":"w14641","DOI":"10.4414\/smw.2018.14641","volume":"148","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Li L, Zhu L, Zhu J, Yang X, Zhou, et al. Adult onset haemophagocytic lymphohistiocytosis prognosis is affected by underlying disease: analysis of a single-institution series of 174 patients. Swiss Med Wkly. 2018;148:w14641. https:\/\/doi.org\/10.4414\/smw.2018.14641.","journal-title":"Swiss Med Wkly"},{"issue":"3","key":"801_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ajh.23911","volume":"90","author":"ZK Otrock","year":"2015","unstructured":"Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol. 2015;90(3):220\u20134. https:\/\/doi.org\/10.1002\/ajh.23911.","journal-title":"Am J Hematol"},{"issue":"2","key":"801_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0889-8588(05)70521-9","volume":"12","author":"G Janka","year":"1998","unstructured":"Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am. 1998;12(2):435\u201344.","journal-title":"Hematol Oncol Clin North Am"},{"key":"801_CR20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/qjmed\/hcy103","volume":"111","author":"M Xie","year":"2018","unstructured":"Xie M, Li L, Zhu L, Zhou YX, Sun J, et al. An effective diagnostic index for lymphoma-associated hemophagocytic syndrome. QJM. 2018;111:541\u20137.","journal-title":"QJM"},{"issue":"11","key":"801_CR21","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00277-013-1784-3","volume":"92","author":"JT Yu","year":"2013","unstructured":"Yu JT, Wang CY, Yang Y, Wang RC, Chang KH, Hwang WL, et al. Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution. Ann Hematol. 2013;92(11):1529\u201336. https:\/\/doi.org\/10.1007\/s00277-013-1784-3.","journal-title":"Ann Hematol"},{"issue":"3","key":"801_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/1097-0142(19930801)72:3<909::aid-cncr2820720341>3.0.co;2-o","volume":"72","author":"AL Cheng","year":"1993","unstructured":"Cheng AL, Su IJ, Chen YC, Uen WC, Wang CH. Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma. Cancer. 1993;72(3):909\u201316. https:\/\/doi.org\/10.1002\/1097-0142(19930801)72:3<909::aid-cncr2820720341>3.0.co;2-o.","journal-title":"Cancer."},{"issue":"2","key":"801_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/rmv.638","volume":"20","author":"NR Maakaroun","year":"2010","unstructured":"Maakaroun NR, Moanna A, Jacob JT, Albrecht H. Viral infections associated with haemophagocytic syndrome. Rev Med Virol. 2010;20(2):93\u2013105. https:\/\/doi.org\/10.1002\/rmv.638.","journal-title":"Rev Med Virol"},{"issue":"4","key":"801_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/10245332.2017.1385191","volume":"23","author":"Z Jin","year":"2018","unstructured":"Jin Z, Wang Y, Wang J, Wu L, Pei R, Lai W, et al. Multivariate analysis of prognosis for patients with natural killer\/T cell lymphoma-associated hemophagocytic lymphohistiocytosis. Hematology. 2018;23(4):228\u201334. https:\/\/doi.org\/10.1080\/10245332.2017.1385191.","journal-title":"Hematology."},{"issue":"1\u20132","key":"801_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cytogfr.2007.01.015","volume":"18","author":"F Salazar-Onfray","year":"2007","unstructured":"Salazar-Onfray F, Lopez MN, Mendoza-Naranjo A. Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. Cytokine Growth Factor Rev. 2007;18(1\u20132):171\u201382. https:\/\/doi.org\/10.1016\/j.cytogfr.2007.01.015.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"801_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/s0002-9440(10)65149-8","volume":"155","author":"G Bellone","year":"1999","unstructured":"Bellone G, Turletti A, Artusio E, Mareschi K, Carbone A, Tibaudi D, et al. Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. Am J Pathol. 1999;155(2):537\u201347. https:\/\/doi.org\/10.1016\/s0002-9440(10)65149-8.","journal-title":"Am J Pathol"},{"issue":"7","key":"801_CR27","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00277-015-2350-y","volume":"94","author":"BI Dalal","year":"2015","unstructured":"Dalal BI, Vakil AP, Khare NS, Wang SY, Richards MJ, Chen LY. Abnormalities of the lymphocyte subsets and their immunophenotype, and their prognostic significance in adult patients with hemophagocytic lymphohistiocytosis. Ann Hematol. 2015;94(7):1111\u20137. https:\/\/doi.org\/10.1007\/s00277-015-2350-y.","journal-title":"Ann Hematol"},{"issue":"29","key":"801_CR28","doi-asserted-by":"publisher","first-page":"e7546","DOI":"10.1097\/MD.0000000000007546","volume":"96","author":"JY Seo","year":"2017","unstructured":"Seo JY, Suh CH, Jung JY, Kim AR, Yang JW, Kim HA. The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: a STROBE-compliant retrospective observational analysis. Medicine (Baltimore). 2017;96(29):e7546. https:\/\/doi.org\/10.1097\/MD.0000000000007546.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"801_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017904","volume":"7","author":"SF Lee","year":"2017","unstructured":"Lee SF, Luque-Fernandez MA. Prognostic value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in follicular lymphoma: a retrospective cohort study. BMJ Open. 2017;7(11):e017904. https:\/\/doi.org\/10.1136\/bmjopen-2017-017904.","journal-title":"BMJ Open"},{"issue":"9","key":"801_CR30","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00277-016-2727-6","volume":"95","author":"Q Bin","year":"2016","unstructured":"Bin Q, Gao JH, Luo JM. Prognostic factors of early outcome in pediatric hemophagocytic lymphohistiocytosis: an analysis of 116 cases. Ann Hematol. 2016;95(9):1411\u20138. https:\/\/doi.org\/10.1007\/s00277-016-2727-6.","journal-title":"Ann Hematol"},{"key":"801_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2016.05.022","volume":"85","author":"SL Yang","year":"2016","unstructured":"Yang SL, Xu XJ, Tang YM, Song H, Xu WQ, Zhao FY, et al. Associations between inflammatory cytokines and organ damage in pediatric patients with hemophagocytic lymphohistiocytosis. Cytokine. 2016;85:14\u20137. https:\/\/doi.org\/10.1016\/j.cyto.2016.05.022.","journal-title":"Cytokine."},{"key":"801_CR32","doi-asserted-by":"publisher","first-page":"456569","DOI":"10.1155\/2014\/456569","volume":"2014","author":"JL Choi","year":"2014","unstructured":"Choi JL, Li S, Han JY. Platelet function tests: a review of progresses in clinical application. Biomed Res Int. 2014;2014:456569\u20137. https:\/\/doi.org\/10.1155\/2014\/456569.","journal-title":"Biomed Res Int"},{"issue":"1","key":"801_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/qjmed\/hcx183","volume":"111","author":"M Zhou","year":"2018","unstructured":"Zhou M, Li L, Zhang Q, Ma S, Sun J, Zhu L, et al. Clinical features and outcomes in secondary adult hemophagocytic lymphohistiocytosis. QJM. 2018;111(1):23\u201331. https:\/\/doi.org\/10.1093\/qjmed\/hcx183.","journal-title":"QJM."},{"key":"801_CR34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/1471-2407-13-350","volume":"13","author":"S Lee","year":"2013","unstructured":"Lee S, Oh SY, Kim SH, Lee JH, Kim MC, Kim KH, et al. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer. 2013;13:350. https:\/\/doi.org\/10.1186\/1471-2407-13-350.","journal-title":"BMC Cancer"},{"issue":"5","key":"801_CR35","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/pbc.21660","volume":"51","author":"K Tamura","year":"2008","unstructured":"Tamura K, Kanazawa T, Tsukada S, Kobayashi T, Kawamura M, Morikawa A. Increased serum monocyte chemoattractant protein-1, macrophage inflammatory protein-1beta, and interleukin-8 concentrations in hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008;51(5):662\u20138. https:\/\/doi.org\/10.1002\/pbc.21660.","journal-title":"Pediatr Blood Cancer"},{"key":"801_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.56","volume":"5","author":"B Xiu","year":"2015","unstructured":"Xiu B, Lin Y, Grote DM, Ziesmer SC, Gustafson MP, Maas ML, et al. IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low\/\u2212) monocytes in B-cell non-Hodgkin lymphoma. Blood Cancer J. 2015;5:e328. https:\/\/doi.org\/10.1038\/bcj.2015.56.","journal-title":"Blood Cancer J"},{"issue":"8","key":"801_CR37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/PAI.0000000000000645","volume":"27","author":"E Matsuki","year":"2019","unstructured":"Matsuki E, Bohn OL, El Jamal S, Pichardo JD, Zelenetz AD, Younes A, et al. Lymphocyte-to-monocyte ratio may serve as a better prognostic Indicator than tumor-associated macrophages in DLBCL treated with rituximab. Appl Immunohistochem Mol Morphol. 2019;27(8):572\u201380. https:\/\/doi.org\/10.1097\/PAI.0000000000000645.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"801_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12935-018-0558-3","volume":"18","author":"L Ai","year":"2018","unstructured":"Ai L, Mu S, Hu Y. Prognostic role of RDW in hematological malignancies: a systematic review and meta-analysis. Cancer Cell Int. 2018;18:61. https:\/\/doi.org\/10.1186\/s12935-018-0558-3.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"801_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.5603\/CJ.2013.0037","volume":"20","author":"S Demirkol","year":"2013","unstructured":"Demirkol S, Balta S, Cakar M, Unlu M, Arslan Z, Kucuk U. Red cell distribution width: a novel inflammatory marker in clinical practice. Cardiol J. 2013;20(2):209. https:\/\/doi.org\/10.5603\/CJ.2013.0037.","journal-title":"Cardiol J"},{"issue":"4","key":"801_CR40","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1043\/1543-2165-133.4.628","volume":"133","author":"G Lippi","year":"2009","unstructured":"Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009;133(4):628\u201332. https:\/\/doi.org\/10.1043\/1543-2165-133.4.628.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"801_CR41","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3324\/haematol.2014.112813","volume":"100","author":"A Maccio","year":"2015","unstructured":"Maccio A, Madeddu C, Gramignano G, Mulas C, Tanca L, Cherchi MC, et al. The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study. Haematologica. 2015;100(1):124\u201332. https:\/\/doi.org\/10.3324\/haematol.2014.112813.","journal-title":"Haematologica."},{"issue":"39","key":"801_CR42","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012342","volume":"97","author":"S Xie","year":"2018","unstructured":"Xie S, Chen X. Red blood cell distribution width-to-platelet ratio as a disease activity-associated factor in systemic lupus erythematosus. Medicine (Baltimore). 2018;97(39):e12342. https:\/\/doi.org\/10.1097\/MD.0000000000012342.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"801_CR43","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3109\/15513819109064797","volume":"11","author":"K Ooe","year":"1991","unstructured":"Ooe K. Pathogenesis of hypofibrinogenemia in familial hemophagocytic lymphohistiocytosis. Pediatr Pathol. 1991;11(4):657\u201361.","journal-title":"Pediatr Pathol"},{"issue":"9","key":"801_CR44","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1517\/14656566.2.9.1437","volume":"2","author":"S Imashuku","year":"2001","unstructured":"Imashuku S, Teramura T, Morimoto A, Hibi S. Recent developments in the management of haemophagocytic lymphohistiocytosis. Expert Opin Pharmacother. 2001;2(9):1437\u201348. https:\/\/doi.org\/10.1517\/14656566.2.9.1437.","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"801_CR45","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/ijlh.12334","volume":"37","author":"W Chen","year":"2015","unstructured":"Chen W, Zhang S, Zhang W, Yang X, Xu J, Qiu H, et al. Elevated serum adenosine deaminase levels in secondary hemophagocytic lymphohistiocytosis. Int J Lab Hematol. 2015;37(4):544\u201350. https:\/\/doi.org\/10.1111\/ijlh.12334.","journal-title":"Int J Lab Hematol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00801-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-020-00801-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00801-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T23:59:55Z","timestamp":1622678395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-020-00801-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["801"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00801-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,3]]},"assertion":[{"value":"21 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures in studies were performed in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}